Utility of cenegermin for the management of neurotrophic keratopathy after penetrating keratoplasty
Following an 8-week course of cenegermin, patients with a history of PK demonstrated improvement in NK stage, epithelial healing, and reduced epithelial defect size lasting 6 months after treatment completion. Patients with prior PK and NK may be considered candidates for cenegermin treatment.
Authors
- Brandon D. Ayres (ORCID: https://orcid.org/0000-0002-8085-7068)
- Zeba A. Syed (ORCID: https://orcid.org/0000-0001-9261-3565)
- Ashley Khalili
- Christopher J. Rapuano (ORCID: https://orcid.org/0000-0002-9141-9522)
- Brenton Finklea
- Alexandra R. Zaloga (ORCID: https://orcid.org/0000-0002-0395-0007)
- Beeran B. Meghpara
Institutions
- Thomas Jefferson University (US)
- Wills Eye Hospital (US)
Publication Details
- Journal
- Oman Journal of Ophthalmology
- Published
- 2025-05-01
- DOI
- https://doi.org/10.4103/ojo.ojo_311_24
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 0.00